AMERICAN NATUROPATHIC RESEARCH INSTITUTE

NATUROPATHIC ONCOLOGY RESEARCH INSTITUTE

Interim address:

1250 E. Baseline Rd., Suite 205

Tempe, AZ 85283

Tel: 480-839-2800

JOINT MEETING OF THE

AMERICAN NATUROPATHIC RESEARCH INSTITUTE (ANRI)

AND THE

NATUROPATHIC ONCOLOGY RESEARCH INSTITUTE (NORI)

AND THE

INTERNATIONAL NATUROPATHIC CLINICAL RESEARCH INSTITUTE

AND THE

INSTITUTIONAL REVIEW BOARD (IRB)

February 12, 2016

MINUTES AND MEETING NOTES


In accordance with the requirements of the United States Code of Federal Regulations, Title 21, Chapter 1, Subchapter A, Part 56, as well as Title 45, Part 46, the twenty-fifth regular quarterly meeting of the American Naturopathic Research Institute (ANRI) and the Naturopathic Oncology Research Institute (NORI) and the International Naturopathic Clinical Research Institute (INCRI) and the Institutional Review Board (IRB) was called to order at 12:15 p.m., February 12, 2016, at 1250 E. Baseline Rd., Suite 205, meeting in Suite 203, Tempe, AZ 85283.

MEMBERS AND GUESTS

14 physicians and 6 non-physicians, including one attorney, were in attendance. This is one of our largest meetings to date.

NEW BOOK

One of the members has authored a manuscript, describing her journey through cancer. She has offered to donate a portion of the proceeds from the sale of the book to the Naturopathic Cancer Society. We very much look forward to seeing the published book.

2015 OMNIBUS APPROPRIATIONS ACT, THE FDA AND IN-OFFICE COMPOUNDING

We discussed the new law, including the US Congress criticizing the FDA’s over-reach and over-interpretation of the Dietary Quality and Supplement Act (DQSA). We discussed the FDA’s reaction, and their confessed motives, and the upcoming hearing they will hold in April 2016.

COMBINATION OF MEDICAL BOARDS

The current AZ governor has pushed for combining all medical boards under the Department of Health Services. We discussed implications of this move for the various medical professions and the public. And we discussed physicians’ response to this.

PATIENTS’ RIGHT TO HAVE MEDICATION OF CHOICE

Patients’ rights to choose their medical treatment are on a collision course with heavy handed government initiatives and legislation. We discussed some of the anticipated flashpoints.

NEW WEBSITE

One physician mentioned a new website, for which we would like content to be generated by physicians, and for them to reap the benefit of public interest in that content.

UPDATES ON ONGOING RESEARCH

The fibrosis study results in all enrolled patients having had some success in reversing fibrosis. They are being tested with a specialized sonogram, rather than the costly, invasive and risky biopsy alternative. Insurance has been paying for this to occur every six months. Gastroenterologists and MDs are referring. Prescription drugs of huge cost are being avoided.

The ARMs are virally caused hepatitis, as well as alcoholic and non-alcoholic fatty liver disease.

No side effects have yet been reported.

The IRB documents for this study amounted to 92 pages.

We then discussed developments in our IRB connections internationally.

GRAND ROUNDS CASE PRESENTATION: SEIZURES AND OTHER NEUROLOGICAL SIGNS

One of the physicians presented a case in which seizures and other neurological signs and symptoms had generally progressed over a number of years, in a patient receiving conventional neurological treatment. The group discussed the case, and then proposed a treatment plan.

EXTORTION EXPERIENCE

One of the physicians recounted two extortion attempts made against that clinic, and how the scheme backfired on the extortionists. There was general dismay and amusement at the end of the narrative.

NEXT MEETING

We agreed to meet in the usual place Friday, May 13, 2016, noon.

The meeting was adjourned at approximately 2:30 pm.